Bristol-Myers Squibb Company
BMY
$45.94
$0.150.33%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.38% | 9.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.38% | 9.53% | |||
| Cost of Revenue | -1.31% | 11.20% | |||
| Gross Profit | -0.03% | 8.92% | |||
| SG&A Expenses | 5.86% | 6.83% | |||
| Depreciation & Amortization | 0.12% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.79% | 6.16% | |||
| Operating Income | -6.63% | 16.86% | |||
| Income Before Tax | 75.73% | -40.36% | |||
| Income Tax Expenses | 99.78% | -9.63% | |||
| Earnings from Continuing Operations | 67.30% | -46.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 400.00% | 66.67% | |||
| Net Income | 68.02% | -46.66% | |||
| EBIT | -6.63% | 16.86% | |||
| EBITDA | -4.18% | 12.60% | |||
| EPS Basic | 67.94% | -46.77% | |||
| Normalized Basic EPS | -3.28% | 13.94% | |||
| EPS Diluted | 68.75% | -46.67% | |||
| Normalized Diluted EPS | -3.28% | 14.28% | |||
| Average Basic Shares Outstanding | 0.05% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.05% | -0.10% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.40% | 0.88% | |||